CHRONIC HEPATITIS B INFECTION
Clinical trials for CHRONIC HEPATITIS B INFECTION explained in plain language.
Never miss a new study
Get alerted when new CHRONIC HEPATITIS B INFECTION trials appear
Sign up with your email to follow new studies for CHRONIC HEPATITIS B INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot aims to tame chronic hepatitis b
Disease control Recruiting nowThis early-stage study tests an injection called AHB-171 in healthy volunteers and people with chronic hepatitis B. The main goals are to check safety, how the body processes the drug, and whether it shows any signs of controlling the virus. About 110 participants will be enrolle…
Matched conditions: CHRONIC HEPATITIS B INFECTION
Phase: PHASE1 • Sponsor: Ausper Biopharma Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New hepatitis b drug shows promise in Mid-Stage trial
Disease control Recruiting nowThis Phase 2 study tests an experimental drug called ALG-000184 against a standard hepatitis B medication (tenofovir) in 200 adults with chronic hepatitis B. Participants take one pill daily for 48 weeks. The main goal is to see if the new drug can lower hepatitis B virus levels …
Matched conditions: CHRONIC HEPATITIS B INFECTION
Phase: PHASE2 • Sponsor: Aligos Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Kidney function may change how hepatitis b drug works
Knowledge-focused Recruiting nowThis early study tests a single dose of the drug pevifoscorvir in 30 people with chronic hepatitis B, some with kidney problems and some with healthy kidneys. Researchers want to see how kidney function affects drug levels and safety. The goal is to learn how to dose the drug pro…
Matched conditions: CHRONIC HEPATITIS B INFECTION
Phase: PHASE1 • Sponsor: Aligos Therapeutics • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC